Cost‑utility analysis of sugemalimab plus chemotherapy as first‑line treatment for advanced gastric cancer
ZHAI Feng, LI Hongyang, WEI Qingqing, TU Qiubo, MAO Jianpeng
Chinese Journal of Hospital Pharmacy . 2026, (6): 698 -703 .  DOI: 10.13286/j.1001-5213.2026.06.13

Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat